Publications

5898 Results

Baseline CT-derived QVT score as predictor of bevacizumab benefit in advanced non-squamous NSCLC: A retrospective biomarker analysis of SWOG S0819

Authors
Zhang K;Mutha P;Haji Maghsoudi O;Hein LB;Li H;Hiremath A;Fu P;Velcheti V;Madabhushi A;Braman N
Journal / Conference
ASCO Annual Meeting (May 29 - June 2, 2026, Chicago, Il); abs 8549 poster 339; J Clin Oncol 44, 2026 (suppl 16; abstr 8549) DOI: 10.1200/JCO.2026.44.16_suppl.8549
Year
2026
Research Committee(s)
Lung
Study Number(s)
S0819

Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICE

Authors
Crew K;Anderson GL;Arnold K;Dzingle SA;Michel A;Delucie M;Law C;Pruthie S;Leon ACS;Shirley R;Gross-Perdekamp MT;Colanna S;Krisher Stacy;King T;Yee L;Ballinger T;Braun-Inglis C;Mangino D;Wisinski L;DeYoung CA;Ross M;Floyd J;Kaster A;Vanderwalde L;Saphner T;Zarwan CL;Lo S;Graham C;Conlin AK;Butler KY;Agnese DM;Jernigan C;Hershman DL;Neuhouser ML;Zell JA;Arun B;Kukafka R
Journal / Conference
J Natl Cancer Inst . 2026 Jul 2:djag216. doi: 10.1093/jnci/djag216. Online ahead of print.
Year
2026
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
42391096
Study Number(s)
S1904

Flow cytometry method to identify arginase-1 expressing MDSCs

Authors
P Srinivasan;M Bechtel;D Wyczechowska;A Ochoa;M Fisch;NL Henry;JM Unger;J Hamilton-Reeves
Journal / Conference
MethodsX, Volume 16, June 2026, 103957. https://doi.org/10.1016/j.mex.2026.103957
Year
2026
Research Committee(s)
Symptom Management and Survivorship
PMID
42233054
PMC
PMC13224384
Study Number(s)
S1600

Immune-Enhancing Nutrition and Outcomes After Radical Cystectomy: A Randomized Clinical Trial

Authors
Hamilton-Reeves JM;Unger JM;Holzbeierlein JM;Lew DL;Ryan MJ;Daneshmand S;Lerner SP;Kukreja JEB;Lee E;Tabayoyong WB;Hershman DL;Fisch MJ;Henry NL
Journal / Conference
JAMA Netw Open. 2026;9(7):e2623622. doi:10.1001/jamanetworkopen.2026.23622
Year
2026
Research Committee(s)
Symptom Management and Survivorship
PMID
42475098
PMC
PMC13386599
Study Number(s)
S1600

A phase II basket trial of DART SWOG S1609: the salivary gland tumor cohort

Authors
Chae YK;Sun R;Patel SP;Giles F;Ohr JP;Worden FP;Suga JM;Naing A;Cohen EE;Wallace J;Kang HS;Fenton S;Chung LY;McLeod CM;Chen HX;Sharon E;Streicher H;Ryan CW;Othus M;Blanke CD;Kurzrock R
Journal / Conference
Ther Adv Med Oncol. 2026 Jul 23;18:17588359261451739. doi: 10.1177/17588359261451739
Year
2026
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
42499790
PMC
PMC13396573
Study Number(s)
S1609

Federal and Industry Sponsorship in US Cancer Clinical Trials

Authors
Unger JM;Xiao H;LeBlanc M;Hershman DL
Journal / Conference
JAMA Oncology. Published online August 20, 2026. doi:10.1001/jamaoncol.2026.3026
Year
2026
Research Committee(s)
Cancer Care Delivery
PMID
42623089
PMC
PMC13494795

Drug Costs in Federally Sponsored Cancer Clinical Trials: A Systematic Review

Authors
Xiao H;LeBlanc M;Bertagnolli M;Threlkel S;Chansky M;Hershman DL;Unger JM
Journal / Conference
JAMA Netw Open. 2026;9(7):e2625814. doi:10.1001/jamanetworkopen.2026.25814
Year
2026
Research Committee(s)
Cancer Care Delivery
PMID
42518232
PMC
PMC13416910

COMMIT: A Randomized Study of mFOLFOX6/Bevacizumab/Atezolizumab or Atezolizumab Alone as First-Line Treatment of Deficient DNA Mismatch Repair Metastatic Colorectal Cancer

Authors
Lima CMSPR;Yothers G;George TJ;Hochster HS;Sanoff HK;Cohen DJ;Guthrie KA;Jacobs SA;Saeed A;Kopetz S;Colangelo LH;Freeman TJ;Cole SW;Khalil MF;Devanna S;Zuckerman DS;Hong TS;Henry NL;Ganz PA;Blanke CD;Wolmark N;Overman MJ
Journal / Conference
J Clin Oncol. Published online July 29, 2026. doi:10.1200/JCO-25-03052
Year
2026
Research Committee(s)
Symptom Management and Survivorship
PMID
41864782
PMC
PMC13105325

Impact of Primary Prophylactic Colony-Stimulating Factor Delivery Method on Febrile Neutropenia: Secondary Analysis of a Pragmatic Cluster Randomized Clinical Trial

Authors
Shih LC;Arnold K;Bansal A;Bell-Brown A;Watabayashi KK;Hershman DL;Ramsey SD
Journal / Conference
JCO Oncology Practice 2026
Year
2026
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S1415CD

Impact of EBV Status and Histology on Patient Outcomes with Nivolumab-AVD vs BV-AVD in Advanced Classic Hodgkin Lymphoma (S1826)

Authors
Ahmed S
Journal / Conference
Blood Adv. 2026 Jul 29:bloodadvances.2026021402. doi: 10.1182/bloodadvances.2026021402.
Year
2026
Research Committee(s)
Lymphoma
PMID
42526889
Study Number(s)
S1826